Uchino J - Search Results

1

Meta-analysis of five studies on tegafur plus uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer.

Kasumi F, Yoshimoto M, Uchino J, Abe R, Nomura Y, Sugimachi K, Nakazato H, Abe O. Kasumi F, et al. Among authors: uchino j. Oncology. 2003;64(2):146-53. doi: 10.1159/000067763. Oncology. 2003. PMID: 12566912

2

The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial.

Tominaga T, Toi M, Abe O, Ohashi Y, Uchino J, Hayasaka H, Abe R, Izuo M, Enomoto K, Watanabe H, Yoshida M, Taguchi T, Koyama H, Senoo T, Toge T, Monden Y, Hattori T, Nomura Y, Sugimachi K, Hirata K, Nakazato H, Miura S, Morimoto T, Asaishi K, Kimijima I, Ota J, Sonoo H, Yamaguchi S; 5'-BC Study Group (5'-DFUR Adjuvant Chemotherapy for Breast Cancer Study Group). Tominaga T, et al. Among authors: uchino j. Int J Oncol. 2002 Mar;20(3):517-25. Int J Oncol. 2002. PMID: 11836563 Clinical Trial.

3

Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.

Noguchi S, Koyama H, Uchino J, Abe R, Miura S, Sugimachi K, Akazawa K, Abe O. Noguchi S, et al. Among authors: uchino j. J Clin Oncol. 2005 Apr 1;23(10):2172-84. doi: 10.1200/JCO.2005.02.158. J Clin Oncol. 2005. PMID: 15800310 Clinical Trial.

4

Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer.

Tominaga T, Abe O, Ohshima A, Hayasaka H, Uchino J, Abe R, Enomoto K, Izuo M, Watanabe H, Takatani O, et al. Tominaga T, et al. Among authors: uchino j. Eur J Cancer. 1994;30A(7):959-64. doi: 10.1016/0959-8049(94)90123-6. Eur J Cancer. 1994. PMID: 7946592 Clinical Trial.

5

[Cooperative Study of Surgical Adjuvant Chemotherapy for Colorectal Cancer (fourth report): five-year results after surgery].

Maehara Y, Sugimachi K, Kikuchi K, Inokuchi K, Komi N, Hattori T, Taguchi T, Kondo T, Abe O, Uchino J, et al. Maehara Y, et al. Among authors: uchino j. Gan To Kagaku Ryoho. 1993 Jan;20(1):109-15. Gan To Kagaku Ryoho. 1993. PMID: 8422174 Clinical Trial. Japanese.

6

Cyclophosphamide, adriamycin, 5-fluorouracil and high-dose toremifene for patients with advanced/recurrent breast cancer. The Japan Toremifene Cooperative Study Group.

Tominaga T, Nomura Y, Uchino J, Hirata K, Kimura M, Yoshida M, Aoyama H, Kinoshita H, Koyama H, Monden Y, Takashima S, Ogawa M. Tominaga T, et al. Among authors: uchino j. Jpn J Clin Oncol. 1998 Apr;28(4):250-4. doi: 10.1093/jjco/28.4.250. Jpn J Clin Oncol. 1998. PMID: 9657010

7

Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials.

Sakamoto J, Teramukai S, Nakazato H, Sato Y, Uchino J, Taguchi T, Ryoma Y, Ohashi Y. Sakamoto J, et al. Among authors: uchino j. J Immunother. 2002 Sep-Oct;25(5):405-12. doi: 10.1097/00002371-200209000-00004. J Immunother. 2002. PMID: 12218778

8

[Phase I study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group].

Nomura Y, Abe O, Enomoto K, Fujiwara K, Tominaga T, Hayashi K, Uchino J, Takahashi M, Hayasaka A, Asaishi K, Okazaki M, Abe R, Kimishima I, Kajiwara T, Haga S, Shimizu T, Miyazaki I, Noguchi M, Yoshida M, Miura S, Taguchi T, Oota J, Sakai K, Kinoshita H, Tashiro H, et al. Nomura Y, et al. Among authors: uchino j. Gan To Kagaku Ryoho. 1998 Mar;25(4):553-61. Gan To Kagaku Ryoho. 1998. PMID: 9530362 Clinical Trial. Japanese.

9

Meta-Analysis of the Second Collaborative Study of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) in Patients with Stage II, Estrogen-Receptor-Positive Breast Cancer.

Yoshida M, Abe O, Uchino J, Kikuchi K, Abe R, Enomoto K, Tominaga T, Fukami A, Sugimachi K, Nomura Y, Hattori T, Ogawa N. Yoshida M, et al. Among authors: uchino j. Breast Cancer. 1997 Jul 31;4(2):93-101. doi: 10.1007/BF02967062. Breast Cancer. 1997. PMID: 11091583

10

Efficacy of Post-operative Adjuvant Therapy for Stage IIIa Berast Cancer: Futraful vs Futraful+Tamoxifen for ER-positive Patients and Futraful vs Futraful+Adriamycin for ER-negative Breast Cancer.

Yoshida M, Abe O, Uchino J, Kikuchi K, Abe R, Enomoto K, Tominaga T, Fukami A, Sakai K, Koyama H, Sugimachi K, Nomura Y, Hattori T, Ogawa N. Yoshida M, et al. Among authors: uchino j. Breast Cancer. 1997 Jul 31;4(2):103-113. Breast Cancer. 1997. PMID: 11091584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

410 results

Search Page